← All companies

APLM

Apollomics, Inc.

APLM Nasdaq Pharmaceutical Preparations EDGAR ↗

$17.25

-0.10 -0.61%

Key statistics

from XBRL data in SEC filings

Market cap

$37.9M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$3.66 – $42.12

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 21, 2026 6-K Jul 14, 2026 6-K Jun 24, 2026 6-K Apr 27, 2026 20-F Apr 24, 2026 6-K Apr 1, 2026 6-K Dec 22, 2025 6-K Dec 12, 2025 6-K Nov 19, 2025 6-K Nov 18, 2025 6-K Oct 21, 2025 6-K FORM 6-K Oct 16, 2025 6-K Oct 14, 2025 6-K FORM 6-K Sep 25, 2025 6-K Sep 5, 2025 6-K Sep 3, 2025 6-K Aug 28, 2025 6-K Jul 25, 2025 20-F Apr 3, 2025 6-K Apr 3, 2025 6-K Mar 31, 2025 6-K Dec 20, 2024 6-K Dec 10, 2024 6-K Nov 14, 2024 6-K Nov 1, 2024 6-K Aug 14, 2024 6-K Aug 1, 2024 6-K Jul 16, 2024 6-K Jul 3, 2024 6-K May 24, 2024 6-K May 8, 2024 6-K Apr 25, 2024 20-F Mar 28, 2024 6-K Mar 28, 2024 6-K Mar 4, 2024 6-K Jan 19, 2024 6-K Jan 8, 2024 6-K Sep 28, 2023 6-K Jul 20, 2023 20-F FORM 20-F Apr 28, 2023